Form 8-K - Current report:
SEC Accession No. 0001213900-25-078539
Filing Date
2025-08-19
Accepted
2025-08-19 16:43:37
Documents
13
Period of Report
2025-08-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0253852-8k_profusa.htm   iXBRL 8-K 23026
2 PRESS RELEASE, DATED AS OF AUGUST 19, 2025 ea025385201ex99-1_profusa.htm EX-99.1 11404
  Complete submission text file 0001213900-25-078539.txt   205562

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pfsa-20250819.xsd EX-101.SCH 3011
4 XBRL LABEL FILE pfsa-20250819_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE pfsa-20250819_pre.xml EX-101.PRE 22356
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0253852-8k_profusa_htm.xml XML 3784
Mailing Address 207 WEST 25TH ST, 9TH FLOOR NEW YORK NY 10001
Business Address 207 WEST 25TH ST, 9TH FLOOR NEW YORK NY 10001 212-494-9022
Profusa, Inc. (Filer) CIK: 0001859807 (see all company filings)

EIN.: 863437271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41177 | Film No.: 251232473
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)